Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (89)
  • Apoptosis
    (83)
  • Antibacterial
    (65)
  • Autophagy
    (65)
  • Antioxidant
    (35)
  • NF-κB
    (35)
  • Antifungal
    (34)
  • Antibiotic
    (25)
  • Reactive Oxygen Species
    (23)
  • Others
    (3208)
Filter
Search Result
Results for "

natural

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5699
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    40
    TargetMol | Compound_Libraries
  • Peptide Products
    39
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    10
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    10
    TargetMol | Dye_Reagents
  • PROTAC Products
    5
    TargetMol | PROTAC
  • Natural Products
    5326
    TargetMol | Natural_Products
  • Reagent Kits
    10
    TargetMol | Reagent_Kits
  • Recombinant Protein
    139
    TargetMol | Recombinant_Protein
  • Isotope Products
    22
    TargetMol | Isotope_Products
  • Antibody Products
    17
    TargetMol | Antibody_Products
  • Disease Modeling
    9
    TargetMol | Disease_Modeling_Products
  • Cell Research
    31
    TargetMol | Inhibitors_Agonists
Thailanstatin A
T388891426953-21-0
Thailanstatin A is an ultra-potent inhibitor of eukaryotic RNA splicing (IC50 = 650 nM). It inhibits multiple cancer cell lines via non-covalent binding to the SF3b subunit of the U2 snRNA subcomplex of the spliceosome, displaying low-nM to sub-nM IC50s. Thailanstatin A, as a payload for ADCs, is conjugated to the lysines on trastuzumab, yielding linker-less ADC.
  • $187
Backorder
Size
QTY
TargetMol | Inhibitor Hot
ARV-393
ARV393
T843162851885-95-3
ARV-393 is a PROTAC degrader targeting BCL6 with the advantage of being highly potent and orally available.ARV-393 recruits BCL6 and E3 ligase cerebellum to rapidly degrade BCL6 through the cell's natural ubiquitin proteasome system for the treatment of diffuse large b-cell lymphoma (DLBCL) and non-Hodgkin's lymphoma (NHL).
  • $223
In Stock
Size
QTY
protac cdk9 degrader-2
T177282435721-30-3
PROTAC CDK9 degrader-2 (compounds 11c) is a potent and selective CDK9 degrader based on PROTAC, with an IC50 of 17 μM in MCF-7 cell lines. Natural product Wogonin binds ubiquitin E3 ligase cereblon (CRBN) via a linker to form PROTAC[1].
  • Inquiry Price
Size
QTY
AcLysValCit-PABC-DMAE-SW-163D
T187372411007-69-5
AcLysValCit-PABC-DMAE-SW-163D is a drug-linker conjugate for antibody-drug conjugates (ADCs), incorporating the natural bis-intercalator SW-163D through an AcLysValCit-PABC-DMAE linker[1].
  • Inquiry Price
Size
QTY
CDK9 Antagonist-1
CDK9 Antagonist-1
T36744
CDK9 Antagonist-1 (compounds 11c) is a potent and selective CDK9 degrader based on PROTAC, with an IC50 of 17 μM in MCF-7 cell lines. Natural product Wogonin binds ubiquitin E3 ligase cereblon (CRBN) via a linker to form PROTAC[1]. CDK9|17 μM (IC50, MCF-7 cells) [1]. Bian J , et al. Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity. Bioorg Chem. 2018 Dec;81:373-381.
  • Inquiry Price
Size
QTY